Showing 1 to 1 of 1 results
euronews.com
🌐 75% Global Worthiness
AstraZeneca's Q4 2024 Earnings Exceed Expectations, Driven by Strong Clinical Trial Results
AstraZeneca announced strong Q4 2024 and full-year results, with total revenue surging 24% to $14.9 billion in Q4 and 18% to $54.1 billion for the full year, driven by successful clinical trials and rising demand across all major therapy areas; CEO Pascal Soriot highlighted this as the start of a ca...
AstraZeneca's Q4 2024 Earnings Exceed Expectations, Driven by Strong Clinical Trial Results
AstraZeneca announced strong Q4 2024 and full-year results, with total revenue surging 24% to $14.9 billion in Q4 and 18% to $54.1 billion for the full year, driven by successful clinical trials and rising demand across all major therapy areas; CEO Pascal Soriot highlighted this as the start of a ca...
Progress
56% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results